Customer account
Document sans nom
 
  Untitled Document
Your partner in CTD & eCTD files - Variations - Risk Management Plan - Environmental Risk Assessment - Preclinical and Clinical - PIL user testing - CEP and ASMF applications - National and DCP MAs - MA Holding - MA Transfer - ICH Q3D Risk analysis - Reimbursement and prices - Market access studies - Consultancy and Quality action plan - Qualification and Validation - Coaching and Communication - GMP training sessions
 
 
ABOUT US
 
 
Didier TERRACOL
Didier Terracol, Pharm D, Ph D, CES, DEPS, specialized in Industrial Pharmaceutic Technics, was founder member, General Manager and QP of the pharmaceutical company Dakota Pharm (1987), then founder member, General Manager and QP of the pharmaceutical company Effik (1992). He is President of Stratégie Santé since 2010.
didier.terracol@strategiesante.com
 
Jennifer GICQUEL
Jennifer Gicquel, Pharm D, DEA for Industrial Pharmaceutic Technics and Biopharmaceutics, is specialized in Pharmaceutical Development. Research Associate in Allergan until 2003, she is Project Manager (Teva) until 2007, then Pharmaceutical Development Manager in the company Effik (2007). She has joined the company in 2011.
jennifer.gicquel@strategiesante.com
 
Didier CLOUVEL
Didier Clouvel, Pharm D, DESS for Industrial Pharmaceutic Technics, is specialized in Regulatory Affairs and Registration (national and international). He has joined Stratégie Santé in 2004.
didier.clouvel@strategiesante.com
 
Marguerite TULLI
Pharm D, Master of Industrial Pharmaceutic Technics and Biopharmaceutics, is specialized in Pharmaceutical Development. Quality Assessor at ANSM (French Agency), then Pharmaceutical Development Project Manager at Excelvision (FAREVA group) and then at Visiotact Pharma, she has joined Stratégie Santé in 2013 as Pharmaceutical Project Manager.
marguerite.tulli@strategiesante.com
 
  Marie-Cécile KRIEF
HCS-QA
Pharm D, DESS for Quality Control of medicines. Qualified person during 15 years in SGS Life Sciences laboratory located in Clichy then Regional GMP Senior Auditor Europe in SGS ICS. Partner of Stratégie Santé since April 2012.
mckrief@hcs-home.com
 
  Alain RUSTERHOLTZ
Consultant
40 years of experience into the pharmaceutical field. Very large networking, editor of “pharma” news and “pharma” books. Has hold several positions and has worked in consulting for many types of companies (pharmaceutical companies, CROs, service providers, institutions, universities). Interventions : business intelligence, marketing, management, training, benchmarking.
alain.rusterholtz@wanadoo.fr
 
  Patricia NURY
Heathics
Medical Doctor, Medical Director and Director of International Clinical Projects in the Pharmaceutical Industry since 1994. Cofounder and Manager of HEATHICS since 2009. Partner of Stratégie Santé since 2012.
contact@heathics.com
 
  Vidal BENATAR
Heathics
Medical Doctor, Medical Affairs and International Drug Development in Global Pharmaceutical Companies since 1978. Cofounder and Manager of HEATHICS since 2009. Partner of Stratégie Santé since 2012.
contact@heathics.com
 
  Catherine LABILLE
5M Partner
Pharmacy PhD, Catherine held various positions, as Production Manager, in Pharmaceutical Industry. She is Quality consultant in Healthcare Industries since 1991.
 
  Gwenaëlle CLECH
5M Partner
Engineer in Food Industries (ENSAIA - National School of Agronomy and Food Industries,), Gwenaëlle has occupied a position of Quality Assurance Manager in Food Industry. She is Quality consultant in Healthcare Industries since 1993.
 
  Monique LAVIGNON
5M Partner
Chemical Engineer (UTC -Technological University of Compiègne), Monique has started her career as Test center manager of a supplier of industrial installation for health industries. She is Quality consultant in Healthcare Industries since 1997.
 
  Corinne SCHOUBRENNER
Consultant
Corinne Schoubrenner, PharmD, DEA for Molecular and Cellular Pharmacology, DESS for Clinical Pharmacology, DU for Antibiotherapy, DIU for Onco-Geriatry, IAE (Business Degree), DU for Pharmacoeconomics. Marketing and business units management in Pharmaceutical Industry since 1991. Independent consultant since 2007. Partner of Stratégie Santé since 2016.
corinne.schoubrenner@wanadoo.fr
 
  Philippe LADURE
PhilippeLadure.SAS
Philippe Ladure, Pharm D, Ph D, DESS in Toxicology (xenobiotiques), DEA in Pharmacology, preclinical development manager for pharmaceutical companies for more than 30 years (Meram Lab, Pierre Fabre Medicament). Founder and President of PhilippeLadure.SAS since 2016. Partner of Stratégie Santé since 2017.